Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hassane Soilihi

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Nature Medicine|January 14, 2014
Activation of a promyelocytic leukemia-tumor protein 53 axis underlies acute promyelocytic leukemia cureJulien Ablain, Kim Rice, Hassane Soilihi, et al.
The Journal of Experimental Medicine|September 22, 2017
PML is a ROS sensor activating p53 upon oxidative stressMichiko Niwa-Kawakita, Omar Ferhi, Hassane Soilihi, et al.
Haematologica|September 11, 2025
Immune intervention is dispensable for retinoic acid/arsenic therapy of murine acute promyelocytic leukemiaCécile Esnault, Gael Fortin, Fang Qiu, et al.
Cancer Cell|July 9, 2010
PML/RARA oxidation and arsenic binding initiate the antileukemia response of As2O3Marion Jeanne, Valérie Lallemand-Breitenbach, Omar Ferhi, et al.
The Journal of Experimental Medicine|November 20, 2002
In vivo activation of cAMP signaling induces growth arrest and differentiation in acute promyelocytic leukemiaMarie-Claude Guillemin, Emmanuel Raffoux, Dominique Vitoux, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Nature Medicine|January 14, 2014
Activation of a promyelocytic leukemia-tumor protein 53 axis underlies acute promyelocytic leukemia cureJulien Ablain, Kim Rice, Hassane Soilihi, et al.
The Journal of Experimental Medicine|September 22, 2017
PML is a ROS sensor activating p53 upon oxidative stressMichiko Niwa-Kawakita, Omar Ferhi, Hassane Soilihi, et al.
Haematologica|September 11, 2025
Immune intervention is dispensable for retinoic acid/arsenic therapy of murine acute promyelocytic leukemiaCécile Esnault, Gael Fortin, Fang Qiu, et al.
Cancer Cell|July 9, 2010
PML/RARA oxidation and arsenic binding initiate the antileukemia response of As2O3Marion Jeanne, Valérie Lallemand-Breitenbach, Omar Ferhi, et al.
The Journal of Experimental Medicine|November 20, 2002
In vivo activation of cAMP signaling induces growth arrest and differentiation in acute promyelocytic leukemiaMarie-Claude Guillemin, Emmanuel Raffoux, Dominique Vitoux, et al.
Pageof 1